KIMBERLY-CLARK CORP (KMB)
NEUTRALFundamental
56
मूल्य
$110.85
मार्केट कैप
$37.04B
भाग 1 · कंपनी का मूल्य कितना है
अवलोकन
Kimberly-Clark makes disposable personal-care and tissue products — diapers (Huggies), feminine and adult care, paper towels and toilet paper (Kleenex, Scott) — sold mainly through supermarkets, mass retailers and pharmacies. Its North America business is the larger and more profitable half; a separate International Personal Care unit sells largely the same categories outside the US and Canada. It is also folding in Kenvue (Tylenol, Band-Aid, Listerine) through a pending acquisition, and moving its non-US tissue business into a joint venture with Brazil's Suzano.
यह पैसा कैसे कमाती है
Kimberly-Clark sells everyday disposable products that customers repurchase every few weeks, so revenue depends on volume and price/mix rather than one-time big-ticket sales. It negotiates directly with a small number of very large retailers — Walmart alone is about 16% of net sales — who control shelf space and can push back hard on price increases, especially when store-brand alternatives sit right next to Kimberly-Clark's products. Profitability rises and falls largely with the cost of pulp, resin and other raw materials relative to what retailers accept in price increases.
सेगमेंट के अनुसार राजस्व
Personal care and tissue brands sold in the US and Canada, Kimberly-Clark's largest and most profitable market.
Diapers, feminine and adult care products sold outside North America, largely in emerging markets.
प्रतिस्पर्धी बढ़त (Moat)
ब्रांड · संकीर्णHuggies, Kleenex and Scott are recognized household names that let Kimberly-Clark charge more than unbranded alternatives and secure shelf space with retailers. But private-label products sit right next to them at lower prices in every category it competes in, and large retailers hold real bargaining power over listing and price, so the brand premium is real but limited rather than dominant.
मांग को क्या चलाता है
डिफेंसिवDiapers, tissue and paper towels are bought regardless of the economic cycle, since consumers rarely cut back on basic hygiene products even in a downturn, which keeps volumes fairly stable. The bigger swing factor is the input-cost cycle — pulp, resin and energy prices — and retailers' willingness to accept the price increases needed to offset it, not end-consumer demand itself.
प्रमुख जोखिम
- Retailer bargaining power — A handful of very large retailers, led by Walmart, control the shelf space Kimberly-Clark depends on and can resist price increases or favor private-label alternatives.
- Raw material cost volatility — Prices for pulp, resin, energy and other key inputs can rise sharply, and Kimberly-Clark may not be able to fully offset them through pricing without hurting volume.
- Kenvue acquisition integration — The pending Kenvue acquisition will substantially increase debt and carries execution risk; the deal could also be delayed, face regulatory obstacles, or fail to deliver the expected synergies.
- Private-label competition — Store-brand competitors, some with significantly lower development and manufacturing costs, offer comparable products at lower prices in nearly every category Kimberly-Clark serves.
ग्राहक Concentration
शीर्ष ग्राहकों का राजस्व में 16% हिस्सा है
Walmart alone accounted for approximately 16% of net sales from continuing operations in 2025, concentrated mostly in the North America segment; losing shelf space or favorable terms with a retailer this size would be difficult to replace elsewhere.
खरीदने के पक्ष में तर्क
Buyers argue that Kleenex, Huggies and Scott are habitual purchases that hold their shelf position through economic cycles, that adding Kenvue's health-care brands diversifies the business beyond paper and diaper categories, and that shedding the lower-margin international tissue business into the Suzano joint venture should lift overall margins.
बेचने के पक्ष में तर्क
Sellers worry that the Kenvue deal loads the balance sheet with new debt right as Kimberly-Clark still has to prove the acquisition's synergies, that a handful of retailers led by Walmart can squeeze pricing whenever input costs rise, and that private-label alternatives keep gaining share in categories where the brand premium is hardest to defend.
Written by the editors, published on 18 अगस्त 2026
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
बैलेंस शीट और तरलता
राजस्व
$16.58B
पिछले 12 महीने (30/6/2026 तक)
शुद्ध आय
$1.96B
पिछले 12 महीने (30/6/2026 तक)
Free Cash Flow
$1.64B
कुल इक्विटी
$1.50B
कुल देनदारियाँ
$15.47B
Current Ratio
0.91
Interest Coverage
9.18
Debt/EBITDA
2.06
Earnings Per Share
राजस्व और शुद्ध आय
Free Cash Flow
आय विवरण
ऐतिहासिक विवरण
समय के साथ मार्जिन
समय के साथ ऋण
ऋण कितना भारी है
वृद्धि तालिका
वृद्धि — राजस्व
Fair Value अनुमान
Fair Value
$105.17
वर्तमान मूल्य
$110.85
Margin of Safety
-5.4%
Fair Value सीमा
$69.32 - $141.03
अनुमान विधियाँ
मूल्यांकन मेट्रिक्स
P/E Ratio
18.94
ROE
134.6%
P/B Ratio
21.17
P/FCF
20.35
Gross Margin
36.8%
ROIC
18.6%
लाभप्रदता Radar
Value Creation (Economic Moat)
ROIC
18.6%
WACC
7.3%
ROIC − WACC
+11.4 pp
ROIC exceeds the cost of capital — the company is creating value for shareholders.
Fundamental विश्लेषण मानदंड
पास (15)
- EPS shows upward trend
- ROIC 18.6%
- Gross Margin 36.8%
- P/FCF 20.35
- Operating Margin 14.3%
- Positive Free Cash Flow
- Current Ratio
- Interest Coverage
- Debt/EBITDA
- Return on Tangible Assets
- ROE 122.6%
- Earnings Surprise avg 2.9%
- Earnings Quality (OCF/NI) 1.70
- Share Dilution -1.2%
- Piotroski F-Score 5/9
फेल (11)
- EPS CAGR 2.23%
- Price CAGR -0.43%
- P/B Ratio 21.17
- Debt/Equity ratio
- CapEx intensity
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Fairly valued)
- Revenue Growth 5Y -3.0%
- Analyst Consensus 43% Buy
- Net Margin Trend 11.8% vs 14.8%
अनुपलब्ध (2)
- Dividend Payout NaN%
- PEG Ratio (need PE > 0 and growth > 0)
Piotroski F-Score
मिश्रित संकेत: कुछ क्षेत्रों पर ध्यान देना आवश्यक
Earnings गुणवत्ता
उच्च गुणवत्ता: earnings नकदी द्वारा समर्थित
शेयर Dilution
शेयर वापस खरीद रही है। शेयरधारक अनुकूल
प्रशासन
कार्यकारी टीम
| नाम | पद | आयु |
|---|---|---|
| Mr. Michael D. Hsu | Chairman & CEO | 61 |
| Mr. Russell C. Torres | President & COO | 53 |
| Mr. Nelson Urdaneta | Senior VP, CFO & Interim Principal Accounting Officer, | 53 |
| Mr. Jeffrey P. Melucci J.D. | Chief Strategy, Business Development & Administrative Officer | 54 |
| Mr. Francesco Tinto | Chief Information & Global Business Services Officer | - |
| Mr. Christopher M. Jakubik C.F.A. | Investor Relations Contact | - |
| Mr. Grant B. McGee J.D. | General Counsel | 44 |
| Ms. Preeti Binoy | Head Corporate Communications & Government Affairs - India | - |
| Ms. Stacey J. Valy Panayiotou | Chief Human Resources Officer | 52 |
| Mr. Ehab Abou-Oaf | Chief Executive Officer of Arbex | 58 |
Audit जोखिम
3
बोर्ड जोखिम
5
मुआवजा जोखिम
6
शेयरधारक अधिकार जोखिम
4
भाग 2 · कीमत और खरीदने का समय
यह हिस्सा यह नहीं बताता कि कंपनी अच्छी है या नहीं: यह तय करने में मदद करता है कि उसे कब खरीदें, जब फंडामेंटल आपको आश्वस्त कर चुके हों। इसमें: तकनीकी विश्लेषण, संभावना, ऐतिहासिक गिरावट, गामा एक्सपोज़र।
Latest News
Recent headlines for KMB, sourced from Markets Gazette.